Improving Cardiovascular Outcomes by Decreasing Residual Risk

1.25 CME
$0 FEE
Improving Cardiovascular Outcomes by Decreasing Residual Risk


Provider Statement

This continuing medical education activity is provided by Vindico Medical Education

Support Statement

This activity is supported by an educational grant from Amarin Pharma Inc.

Target Audience

The intended audience for this activity is cardiologists, internists and other health care professionals involved in the management of patients with, or at risk for, cardiovascular disease.

Learning Objectives

Upon successful completion of this activity, participants should be better able to: 

  • Utilize appropriate methods to assess residual risk in patients with controlled LDL-C.
  • Evaluate the latest clinical evidence regarding cardiovascular outcomes trials and the implications for primary and secondary prevention.
  • Identify patients who may benefit from additional treatment to reduce cardiovascular risk despite the management of other risk factors and manage them accordingly.

Activity Chair

Pamela B. Morris, MD, FACC, FAHA, FASPC, FNLA
Professor of Medicine, Cardiology
Director, Seinsheimer Cardiovascular Health Program
The Medical University of South Carolina
Charleston, SC


Deepak L. Bhatt, MD, MPH, FACC,
Executive Director of Interventional
Cardiovascular Programs
Brigham and Women’s Hospital Heart and
Vascular Center
Professor of Medicine
Harvard Medical School
Boston, MA

Ann Marie Navar, MD, PhD
Associate Professor of Medicine
Division of Cardiology
UT Southwestern Medical Center
Dallas, TX


Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
Ronald A. Codario, Jr., MD


Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation

Vindico Medical Education designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity enables the participant to earn up to 1.25 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC points.

Participants who opt-in will earn MOC points equivalent to the amount of CME credits claimed for the activity.

This enduring material is approved for 1 year from the date of original release, December 17, 2020, to December 16, 2021.


MIPS Qualifying Activity

Completion of this accredited CME activity meets the expectations of an Accredited Safety or Quality Improvement Program (IA_PSPA_28) for the Merit-based Incentive Payment Program (MIPS). Participants who successfully complete the activity and its performance assessment will receive printable documentation of successful completion for MIPS self-reporting.

To meet the criteria for improvement activities in the Merit-based Incentive Payment System (MIPS) of QPP, accredited CME providers need
to implement activities that:

  • address a quality or safety gap that is supported by a needs assessment or problem analysis or support the completion of such a needs assessment as part of the activity;
  • have specific, measurable aim(s) for improvement;
  • include interventions intended to result in improvement;
  • include data collection and analysis of performance data to assess the impact of the interventions; and
  • define meaningful clinician participation in their activity, describe the mechanism for identifying clinicians who meet the requirements, and provide participant completion information.

How to Participate in This Activity and Obtain CME Credit

To participate in this CE activity, you must read the objectives, answer the pretest questions, view the content, and complete the posttest and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 3 out of 4 of the posttest questions correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ Certificate.


In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all accredited providers are required to mitigate and disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of accredited content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the accredited activity content over which the individual has control. Relationship information appears below.

Faculty reports the following relationship(s)

Contracted Research: Abbott Medical Optics, Aimmune, Amarin, Amgen,
AstraZeneca, Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, Cardax,
Chiesi, CSL Behring, Eisai, Ethicon, Ferring, Forest Laboratories, Fractyl,
Idorsia, Ironwood, Ischemix, Lexicon, Lilly, Medtronic, MyoKardia, Pfizer,
PhaseBio, Regeneron, PLx Pharma, Regeneron, Roche, Sanofi-Aventis,
Synaptic, The Medicines Company

Pamela B. Morris, MD, FACC, FAHA, FASPC, FNLA
Consulting Fee: Amgen, Esperion

Ann Marie Navar, MD, PhD
Consulting Fee: 89bio, Amarin, Amgen, AstraZeneca, Boehringer
Ingelheim, Cerner, Esperion, Janssen, Lilly, New Amsterdam, Novartis,
Novo Nordisk, Pfizer, Regeneron, Sanofi, The Medicines Company
Contracted Research: Amarin, Amgen, Janssen, Regeneron, Sanofi

Reviewers report the following relationship(s)

Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
No relevant financial relationships to disclose.

Ronald A. Codario, Jr., MD
No relevant financial relationships to disclose.

Vindico Medical Education staff report the following relationship(s)

No relevant financial relationships to disclose.

Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.

Unlabeled and Investigational Usage

The audience is advised that this continuing education activity may contain references to unlabeled uses of US Food and Drug Administration (FDA)-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non–FDA-approved or investigational use of products/devices.

Copyright Statement

Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2020 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Vindico Medical Education continuing medical education activities does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.

CME Questions?

Contact us at